Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF)

Autor: Kailainathan, Sumangali, Piers, Thomas M., Yi, Jee Hyun, Choi, Seongmin, Fahey, Mark S., Borger, Eva, Gunn-Moore, Frank J., O’Neill, Laurie, Lever, Michael, Whitcomb, Daniel J., Cho, Kwangwook, Allen, Shelley J.
Přispěvatelé: University of St Andrews. School of Biology, University of St Andrews. Institute of Behavioural and Neural Sciences, University of St Andrews. Biomedical Sciences Research Complex
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
DIV
days in vitro

IPTG
isopropyl β-D-1-thiogalactopyranoside

Long-Term Potentiation
LD
luminal domain

chemical compounds studied in this article
Hippocampus
Mice
LTP
long-term potentiation

NAD
nicotinamide adenine dinucleotide

binding kinetics
CD
circular dichroism

ANOVA
analysis of variance

Cells
Cultured

Membrane Potential
Mitochondrial

Neurons
Pro-brain-derived neurotrophic factor (proBDNF)
Neuronal Plasticity
LDH
lactate dehydrogenase

neurotrophin receptor
TrkB
tyrosine kinase B

fEPSP
field excitatory postsynaptic potentials

Neurotrophin receptors
SNP
single nucleotide polymorphism

Recombinant Proteins
aCSF
artificial cerebrospinal fluid

PMS
phenazinemethosulfate

Chemical compounds studied in this article
BDNF
brain-derived neurotrophic factor

Val66Met polymorphism
JC-1 dye
5′
6
6′-tetrachloro-1
1′
3
3′-tetraethylbenzimidazolylcarbocyanine iodide

neurotrophin receptors
RM
LTD
long-term depression

NDAS
SPR
surface plasmon resonance

tau Proteins
QH426 Genetics
AD
Alzheimer’s disease

Article
SDG 3 - Good Health and Well-being
GSK3β
glycogen synthase kinase 3β

Animals
Humans
p75NTR
pan-neurotrophin receptor

FCR
furin cleavage-resistant

Protein Precursors
Rats
Wistar

QH426
ComputingMethodologies_COMPUTERGRAPHICS
Pharmacology
PONDR
predictor of naturally disordered regions

Glycogen Synthase Kinase 3 beta
Polymorphism
Genetic

L-Lactate Dehydrogenase
Brain-Derived Neurotrophic Factor
Long-term depression (LTD)
ECD
extracellular domain

TrkBIg2
TrkB immunoglobulin-like domain 2

WT
wild-type

SDS PAGE
sodium dodecyl sulfate polyacrylamide electrophoresis

RM Therapeutics. Pharmacology
long-term depression (LTD)
Binding kinetics
DTT
dithiothreitol

s.e.m.
standard error of mean

Synapses
RU
response units
Zdroj: Kailainathan, S, Piers, T M, Yi, J H, Choi, S, Fahey, M S, Borger, E, Gunn-Moore, F J, O'Neill, L, Lever, M, Whitcomb, D J, Cho, K & Allen, S J 2016, ' Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF) ', Pharmacological Research, vol. 104, pp. 97-107 . https://doi.org/10.1016/j.phrs.2015.12.008
Kailainathan, S, Piers, T M, Yi, J H, Choi, S M, Fahey, M S, Borger, E, Gunn-Moore, F J, O'Neill, L, Lever, M, Whitcomb, D J, Cho, K & Allen, S J 2016, ' Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF) ', Pharmacological Research, vol. 104, pp. 97-107 . https://doi.org/10.1016/j.phrs.2015.12.008
Kailainathan, S, Piers, T M, Yi, J H, Choi, S, Fahey, M S, Borger, E, Gunn-Moore, F J, O'Neill, L, Lever, M, Whitcomb, D J, Cho, K & Allen, S J 2016, ' Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF) ', Pharmacological Research, vol. 104, no. 0, pp. 97-107 . https://doi.org/10.1016/j.phrs.2015.12.008
Pharmacological Research
DOI: 10.1016/j.phrs.2015.12.008
Popis: Graphical abstract
This study describes a fundamental functional difference between the two main polymorphisms of the pro-form of brain-derived neurotrophic factor (proBDNF), providing an explanation as to why these forms have such different age-related neurological outcomes. Healthy young carriers of the Met66 form (present in ∼30% Caucasians) have reduced hippocampal volume and impaired hippocampal-dependent memory function, yet the same polymorphic population shows enhanced cognitive recovery after traumatic brain injury, delayed cognitive dysfunction during aging, and lower risk of late-onset Alzheimer’s disease (AD) compared to those with the more common Val66 polymorphism. To examine the differences between the protein polymorphisms in structure, kinetics of binding to proBDNF receptors and in vitro function, we generated purified cleavage-resistant human variants. Intriguingly, we found no statistical differences in those characteristics. As anticipated, exogenous application of proBDNF Val66 to rat hippocampal slices dysregulated synaptic plasticity, inhibiting long-term potentiation (LTP) and facilitating long-term depression (LTD). We subsequently observed that this occurred via the glycogen synthase kinase 3β (GSK3β) activation pathway. However, surprisingly, we found that Met66 had no such effects on either LTP or LTD. These novel findings suggest that, unlike Val66, the Met66 variant does not facilitate synapse weakening signaling, perhaps accounting for its protective effects with aging.
Databáze: OpenAIRE